Cardionovum

Be up
to date.

Latest press release

RESTORE® Drug-Coated Balloon receives first Chinese FDA medical device registration certificate for two indications

RESTORE®, CARDIONOVUM’s innovative paclitaxel-coated balloon for coronary applications has received market approval for China, making it the first drug-coated balloon (DCB) available in China to treat two indications: in-stent restenosis (ISR) and small vessel disease (SVD). The approval was given based on the impressive results from two solidly designed clinical studies in Chinese populations: RESTORE ISR CHINA and RESTORE SVD CHINA.

Learn more >>

J.C. van den Berg discusses results from the APERTO AVF study

Learn more >>

Koen Deloose discusses final results from the Reflow trial

Learn more >>

Matteo Tozzi discusses new data from the APERTO AVF study

Learn more >>

Dr. Bosier interview at LINC 2019

Learn more >>

CARDIONOVUM Press Release: RESTORE® Drug-Coated Balloon Matches Zotarolimus-Eluting Stent in Patients with Coronary Small Vessel Lesions

Learn more >>

Upcoming events

Cardionovum® at DEBS 2025

Cardionovum® is pleased to invite you to visit us at booth #4.

Location:

NH Collection Vittorio Veneto
Corso d’Italia 1,
00198 Rome
Italy

Date: Jan 30, 2025–Jan 31, 2025

Latest events

Cardionovum at LINC

Cardionovum participates at LINC Leipzig Interventional Course

Date: Jan 24, 2017–Jan 28, 2017

Location: Leipzig, Germany

Learn more >>

Visit website >>

Cardionovum at CIRSE

Cardionovum participates at CIRSE

Date: Sep 09, 2016–Sep 14, 2016

Location: Barcelona, Spain

Visit website >>

Cardionovum at EuroPCR

Cardionovum participates at EuroPCR

Date: May 16, 2016–May 20, 2016

Location: Paris, France

Visit website >>

go top